Who are Precise Bio's investors?

Precise Bio's investors include K20 Fund.

How much funding has Precise Bio raised?

Precise Bio has disclosed $27.5M raised across 2 rounds.

Where is Precise Bio headquartered?

Precise Bio is headquartered in Winston-Salem, US.

Precise Bio

Winston-Salem, US · Delaware corporation · 1 known investors

Precise Bio is a regenerative medicine company that develops bio-printed tissues and organs using a 4D bio-fabrication platform, initially focused on ophthalmology including a fabricated human cornea program. It serves patients with unmet medical needs that cannot be met with donor tissue, with facilities in North Carolina, USA and Shoham, Israel.

Biotech Deep Tech Medical Devices

Founders & leadership

Anthony AtalaNamed on SEC filing

Avi KatzNamed on SEC filing

Shay SokerNamed on SEC filing

Aryeh BattNamed on SEC filing

Ilan LiorNamed on SEC filing

Yalon FarhiNamed on SEC filing

Investors · 1

K20 FundValley Stream · $100K – $2.5M

Reported raises · per SEC filings

Form D private placements

$27.5M disclosed across 2 rounds · 2018–2022

▶$12MraisedJan 2024 · 8 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nathan CaliDirector
Viko DanaDirector
Aryeh BattExecutive Officer, Director, Promoter
Shay SokerDirector, Promoter
Dirk MuehlhoffDirector
Ilan LiorDirector
Ori HadimiExecutive Officer, Director
Avi KatzDirector
Anthony AtalaDirector, Promoter

Offering amount: $25M
Amount sold: $12M
Minimum investment: $75K
Sales commissions: $75K
Proceeds to insiders: $700K
Placement agents: Michael Avruch
First sale: Jul 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$15.5MraisedFeb 2022 · 70 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Anthony AtalaDirector, Promoter
Avi KatzExecutive Officer, Director
Shay SokerDirector, Promoter
Aryeh BattExecutive Officer, Director, Promoter
Ilan LiorDirector
Yalon FarhiDirector

Offering amount: $15.5M
Amount sold: $15.5M
Minimum investment: $15K
Sales commissions: $730K
Finders' fees: $557K
Proceeds to insiders: $700K
Placement agents: Nobel Capital
First sale: Nov 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Precision BioSciences8 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

Precision For Medicine5 shared keywordsPrecision for Medicine is a contract research organization that provides clinical trial management and regulatory support for drug development programs, including oncology, hematology, cell and gene therapy, CAR-T, and radiopharmaceutical trials. It serves pharmaceutical and biotech sponsors running multinational Phase I–IV studies.

Precision4 shared keywordsPrecision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts. The company works with hospital clinical partners on implanted studies and positions its technology as removable and upgradable without damaging the brain.

PrintBio3 shared keywordsPrintBio is a clinical- and commercial-stage biotechnology company developing 3D-bioprinting and material science technologies to create bioresorbable surgical mesh products, including its DynaFlex and DynaForm Programmable Surgical Mesh lines for soft tissue repair and reinforcement. Working with surgeons, the company also builds living tissue implants for patients in regenerative medicine.

Precision Medicine Group, Inc.3 shared keywordsPrecision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.

Companies competing with Precise Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Precise Bio do?: Precise Bio is a regenerative medicine company that develops bio-printed tissues and organs using a 4D bio-fabrication platform, initially focused on ophthalmology including a fabricated human cornea program. It serves patients with unmet medical needs that cannot be met with donor tissue, with facilities in North Carolina, USA and Shoham, Israel.
Who are Precise Bio's investors?: Precise Bio's investors include K20 Fund.
How much funding has Precise Bio raised?: Precise Bio has disclosed $27.5M raised across 2 rounds.
Where is Precise Bio headquartered?: Precise Bio is headquartered in Winston-Salem, US.